Zhuang H - Search Results

1

Ma H, Qu J, Pang Z, Luo J, Yan M, Xu W, Zhuang H, Liu L, Qu Q. Ma H, et al. Among authors: zhuang h. Mol Cancer. 2024 Aug 1;23(1):153. doi: 10.1186/s12943-024-02066-z. Mol Cancer. 2024. PMID: 39090713 Free PMC article. Review.

2

The Emerging Role of Super-enhancers as Therapeutic Targets in The Digestive System Tumors.

Li XP, Qu J, Teng XQ, Zhuang HH, Dai YH, Yang Z, Qu Q. Li XP, et al. Int J Biol Sci. 2023 Jan 22;19(4):1036-1048. doi: 10.7150/ijbs.78535. eCollection 2023. Int J Biol Sci. 2023. PMID: 36923930 Free PMC article. Review.

3

Superenhancers as master gene regulators and novel therapeutic targets in brain tumors.

Zhuang HH, Qu Q, Teng XQ, Dai YH, Qu J. Zhuang HH, et al. Exp Mol Med. 2023 Feb;55(2):290-303. doi: 10.1038/s12276-023-00934-0. Epub 2023 Feb 1. Exp Mol Med. 2023. PMID: 36720920 Free PMC article. Review.

4

Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer.

Tang ZC, Qu Q, Teng XQ, Zhuang HH, Xu WX, Qu J. Tang ZC, et al. Front Pharmacol. 2023 Jul 27;14:1192855. doi: 10.3389/fphar.2023.1192855. eCollection 2023. Front Pharmacol. 2023. PMID: 37576806 Free PMC article.

5

Corrigendum: Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer.

Tang ZC, Qu Q, Teng XQ, Zhuang HH, Xu WX, Qu J. Tang ZC, et al. Front Pharmacol. 2023 Sep 5;14:1285522. doi: 10.3389/fphar.2023.1285522. eCollection 2023. Front Pharmacol. 2023. PMID: 37736346 Free PMC article.

6

The Burgeoning Significance of Liquid-Liquid Phase Separation in the Pathogenesis and Therapeutics of Cancers.

Xu WX, Qu Q, Zhuang HH, Teng XQ, Wei YW, Luo J, Dai YH, Qu J. Xu WX, et al. Int J Biol Sci. 2024 Feb 12;20(5):1652-1668. doi: 10.7150/ijbs.92988. eCollection 2024. Int J Biol Sci. 2024. PMID: 38481812 Free PMC article. Review.

7

Small Interfering RNA for Gliomas Treatment: Overcoming Hurdles in Delivery.

Teng XQ, Qu J, Li GH, Zhuang HH, Qu Q. Teng XQ, et al. Front Cell Dev Biol. 2022 Jul 8;10:824299. doi: 10.3389/fcell.2022.824299. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35874843 Free PMC article. Review.

8

Individualized antibiotic dosage regimens for patients with augmented renal clearance.

Shi AX, Qu Q, Zhuang HH, Teng XQ, Xu WX, Liu YP, Xiao YW, Qu J. Shi AX, et al. Front Pharmacol. 2023 Jul 26;14:1137975. doi: 10.3389/fphar.2023.1137975. eCollection 2023. Front Pharmacol. 2023. PMID: 37564179 Free PMC article. Review.

9

Personalized application of antimicrobial drugs in pediatric patients with augmented renal clearance: a review of literature.

Xu WX, Qu Q, Teng XQ, Zhuang HH, Liu SF, Wang Y, Qu J. Xu WX, et al. Eur J Pediatr. 2024 Jan;183(1):51-60. doi: 10.1007/s00431-023-05272-x. Epub 2023 Oct 20. Eur J Pediatr. 2024. PMID: 37861791 Review.

10

Nephrotoxicity and Efficacy Assessment of Polymyxin B Use in Renal Transplant Patients.

Wen YX, Qu Q, Long WM, Luo Y, Zhuang HH, Teng XQ, Qu J. Wen YX, et al. Infect Drug Resist. 2022 Jan 26;15:275-283. doi: 10.2147/IDR.S348571. eCollection 2022. Infect Drug Resist. 2022. PMID: 35115795 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,614 results

Search Page

Filters